Work

Development and Scale-Up of an Enabling Synthetic Route to KTX-005, a Muscarinic Acetylcholine Receptor Agonist for the Potential Treatment of Schizophrenia

Year: 2025

Type: article

Source: Organic Process Research & Development

DOI: 10.1021/acs.oprd.4c00531

Authors: Hanchao Zheng, Rui Zhang, Michel Leeman, Christopher R. H. Hale, Giorgio Attardo, Vijaya B. Gondi

Institutions: WuXi AppTec (China), Bristol-Myers Squibb (United States)

Language: English

Topic: Asymmetric Synthesis and Catalysis

Subfield: Organic Chemistry

Field: Chemistry

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Bristol-Myers Squibb

OpenAlex ID: W4407188218

FWCI: 0.596

Cites: 39

Cited by: 2

Related to: 10